Peptide Science

Peptides are short chains of amino acids — typically between 2 and 50 residues — linked by peptide bonds. Unlike larger proteins, their smaller size allows for targeted biological activity with high specificity and reduced immunogenicity.

Research into peptide therapeutics has expanded dramatically, with over 80 peptide drugs approved globally and hundreds more in clinical trials. Key areas of investigation include metabolic regulation, immune modulation, antimicrobial activity, and tissue repair.

At Evidence Labs, our peptide compounds are synthesized using solid-phase peptide synthesis (SPPS) methodology, purified via reverse-phase HPLC, and verified through mass spectrometry analysis.

Recovery & Tissue Repair Research

The study of tissue repair mechanisms has identified several peptide families with significant regenerative potential. Body Protection Compound (BPC) peptides and Thymosin Beta-4 derivatives are among the most actively researched compounds in this domain.

BPC-157, a pentadecapeptide derived from gastric juices, has demonstrated activity in over 20 different tissue types in preclinical studies. Its proposed mechanisms include upregulation of growth factor receptors, modulation of nitric oxide pathways, and promotion of angiogenesis.

TB-500, a synthetic fragment of Thymosin Beta-4, promotes cellular migration through actin polymerization — a fundamental process in wound healing, inflammation resolution, and tissue remodeling.

Metabolic Research & GLP-1 Science

The study of tissue repair mechanisms has identified several peptide families with significant regenerative potential. Body Protection Compound (BPC) peptides and Thymosin Beta-4 derivatives are among the most actively researched compounds in this domain.

BPC-157, a pentadecapeptide derived from gastric juices, has demonstrated activity in over 20 different tissue types in preclinical studies. Its proposed mechanisms include upregulation of growth factor receptors, modulation of nitric oxide pathways, and promotion of angiogenesis.

TB-500, a synthetic fragment of Thymosin Beta-4, promotes cellular migration through actin polymerization — a fundamental process in wound healing, inflammation resolution, and tissue remodeling.

Growth Hormone Pathways

The study of tissue repair mechanisms has identified several peptide families with significant regenerative potential. Body Protection Compound (BPC) peptides and Thymosin Beta-4 derivatives are among the most actively researched compounds in this domain.

BPC-157, a pentadecapeptide derived from gastric juices, has demonstrated activity in over 20 different tissue types in preclinical studies. Its proposed mechanisms include upregulation of growth factor receptors, modulation of nitric oxide pathways, and promotion of angiogenesis.

TB-500, a synthetic fragment of Thymosin Beta-4, promotes cellular migration through actin polymerization — a fundamental process in wound healing, inflammation resolution, and tissue remodeling.